To better understand human adaptation to stress, and in particular to hypoxia, we took advantage of one of nature's experiments at high altitude (HA) and studied Ethiopians, a population that is well-adapted to HA hypoxic stress. Using whole-genome sequencing, we discovered that EDNRB (Endothelin receptor type B) is a candidate gene involved in HA adaptation. To test whether EDNRB plays a critical role in hypoxia tolerance and adaptation, we generated EdnrB knockout mice and found that when EdnrB −/+ heterozygote mice are treated with lower levels of oxygen (O 2 ), they tolerate various levels of hypoxia (even extreme hypoxia, e.g., 5% O 2 ) very well. For example, they maintain ejection fraction, cardiac contractility, and cardiac output in severe hypoxia. Furthermore, O 2 delivery to vital organs was significantly higher and blood lactate was lower in EdnrB −/+ compared with wild type in hypoxia. Tissue hypoxia in brain, heart, and kidney was lower in EdnrB −/+ mice as well. These data demonstrate that a lower level of EDNRB significantly improves cardiac performance and tissue perfusion under various levels of hypoxia. Transcriptomic profiling of left ventricles revealed three specific genes [natriuretic peptide type A (Nppa), sarcolipin (Sln), and myosin light polypeptide 4 (Myl4)] that were oppositely expressed (q < 0.05) between EdnrB −/+ and wild type.
Functions related to these gene networks were consistent with a better cardiac contractility and performance. We conclude that EDNRB plays a key role in hypoxia tolerance and that a lower level of EDNRB contributes, at least in part, to HA adaptation in humans.
Endothelin receptor type B | hypoxia | high altitude | cardiac output | lactate O xygen (O 2 ) is often referred to as a biosignature, a chemical marker in the atmosphere closely associated with life, and in a complex organism, such as humans, various physiological systems have evolved to maintain an optimal O 2 homeostasis. Arguably, humans living at high altitude (HA) for thousands of years ought to have undergone a significant level of natural selection to adjust to the challenging hypoxic condition. Human adaptation to HA hypoxia, which can be protective to tissues, can potentially be harnessed for better therapeutic modalities for sea-level diseases that involve hypoxia and ischemia in their pathogenesis. Indeed, lessons from such an "experiment in nature" can be derived from HA adaptation and can advance lowaltitude medicine (1) . With the advent of newer technology including next-generation sequencing (seq), this idea has recently led to intensive efforts, and a number of publications have appeared on studies of human populations living at HA (2) (3) (4) . These studies also draw added significance not only to sea-level human diseases but also to more than 140 million people living at an altitude above 2,500 m, where the hypoxic condition presents a major challenge for survival (5) . Although a number of laboratory methods that mimic hypoxia adaptation using model organisms (6) have been used as tools to identify causative genetic pathways (7, 8) , studies in human populations living at different HA regions with distinct genetic backgrounds can provide direct insight for identifying mechanisms regulating hypoxia responses in humans.
Over the last few decades, much research has been done on humans permanently living at high altitude. Although there is still debate about the mechanisms of adaptation in HA populations, especially in relation to those populations that are beststudied (9) , the Ethiopians are considered to be the best-adapted because the prevalence of chronic mountain sickness, a maladaptation syndrome to HA, has never been reported (10, 11) . In our recent effort to understand the basis for adaptation to HA in humans, we analyzed the whole genome for genetic variation in HA Ethiopians (4) . Using cross-population tests of selection, we searched for genomic regions with a significant loss of genetic diversity indicative of selective sweeps (4) . We discovered several regions on different chromosomes that were significantly associated with HA adaptation. To elucidate the potential role of each of the individual genes in hypoxia adaptation and tolerance, we experimentally evaluated whether these genes affected hypoxia tolerance in Drosophila by manipulating respective orthologs in the fly. Indeed, we succeeded in functional evaluation of some of these candidate genes in flies (4). However, Endothelin receptor B (EDNRB), which is one of these significant candidate genes [chromosome (chr)13], had no ortholog in flies (4).
Significance
Although model organisms have been used to understand the underlying basis of hypoxia and how to treat it, it has always been useful to learn from natural experiments in humans, such as in high-altitude dwellers. In this study, we demonstrate that decreased Endothelin receptor type B (EdnrB), a gene associated with altitude adaptation from our human study, improves cardiac tolerance to hypoxia. We show that heterozygote EdnrB mice maintain higher cardiac output and peripheral perfusion and better O 2 delivery to vital organs, even in severe hypoxia. Furthermore, the transcriptome profile revealed three atriaspecific genes, natriuretic peptide type A (Nppa), sarcolipin (Sln), and myosin light polypeptide 4 (Myl4), which were down-regulated by hypoxia and possibly have a role in improving cardiac performance during normoxia and hypoxia.
To functionally validate and study the role of this candidate gene, we resorted to experiments in mice. Given that HA exposure has long been recognized as a cardiac stress (12) and endothelin (ET) receptor blockade with bosentan ameliorates an increase in pulmonary artery pressure (13) with hypoxia, we hypothesized that a decreased level of EDNRB would play a protective role in HA hypoxia. In addition, it appears that EdnrA-specific antagonism affects only pulmonary hypertension with no effect on cardiac performance (14) . This supported the notion that EdnrB-specific antagonism of bosentan would improve cardiac performance at high altitude. Because EdnrB is widely expressed (15), we generated an EdnrB global knockout mouse model and used the heterozygous (EdnrB −/+ ) to evaluate its role in cardiovascular response to various degrees of hypoxia from mild to severe. We report here, to our knowledge for the first time, a major heterozygous advantage of EdnrB under hypoxic conditions and its cross-talk with three specific genes that were differentially expressed in the ventricles.
Results
Genomic Analysis of EDNRB Reveals Fixation of SNPs in the HA Population. Earlier, we reported EDNRB as one of our top candidates for genes underlying hypoxia adaptation in Ethiopian highlanders (4) . This HA population showed a strong signature of selection in the EDNRB region, with a large block of fixed SNPs that was observed at significantly lower frequencies in lowlander controls (Table S1 ). Upon reanalyzing the sequenced data of the region containing EDNRB, we noted a large block of 52 "differential" SNPs upstream of the promoter region of EDNRB (Fig.  1A) , 20 of which were located near a cluster of ENCODE project (genome.ucsc.edu/ENCODE/index.html) transcription-factor binding sites (TFBSs). This region is also depicted with a stronger signal for the layered H3K4Me1 (H3 histone protein, lysine 4, monomethylation; Fig. 1A , pink line) histone mark across the genome as determined by ChIP-seq assay. Indirectly, H3K4Me1 is associated with enhancers and with DNA regions downstream of the transcription start site. The signal peak was observed primarily in the HUVEC (human umbilical vein endothelial cell) tissue type, represented in Fig. 1A as light blue peaks, implying that potential disruption of this site would be consistent with blood vessel-related phenotypes. Five of these SNPs overlapped with the ENCODE TFBSs (Table S2 ). This includes binding sites for transcription factors such as ATF2, FOXM1, STAT3, and MEF2A (Fig. 1B) , which are reported to have roles in cardiac function either independently (16, 17) or in cross-talk with the endothelin system (18, 19) . Also, within this cluster, the strongest signal was a 400-bp Chip-seq peak for the FOS/JUN (chr13:78503006-78503405; Fig. 1B ) transcription factors reported as related to hypoxia and angiogenesis (20) . Although we did not find any SNPs lying within this stretch of sequence, three SNPs were flanking FOS/JUN and were at 100% in the Amhara population and roughly 66% in the Oromo population, both HA populations. Furthermore, this peak appears to overlap a DNaseI-hypersensitive region, observed mainly in blood and lymphatic endothelial cells. These observations, and the fact that this region is in the 5′ region of EDNRB or within the first intron of one of the EDNRB transcripts, reference sequence (RefSeq) accession no. NM_000115 (Fig. 1A) , makes it unlikely that the strong signature of selection in the EDNRB region was purely by chance. Although the SNPs in the EdnrB promoter region play a role (21), our rationale for hypothesizing that they render EdnrB hypofunctional are data obtained from the clinical use of bosentan in patients at high altitude.
Generation of EdnrB Heterozygous Mice. We hypothesized that decreasing functional EDNRB would be advantageous in hypoxia, and hence we knocked out this gene in a mouse model and then studied its phenotype in both normoxia and hypoxia. Using a Cre-Lox recombination system, exon 3 from EdnrB flox/flox was completely removed (Fig. 2A) . A detailed strategy is provided in SI Materials and Methods and Fig. S1 . This resulted in an out-offrame transcript of exon 2-exon 4 splicing, making the gene nonfunctional (22) . As we expected, the complete knockout of EdnrB (EdnrB −/− ) led to a phenotype observed in the Hirschsprung mouse model and accordingly dies at around weaning age (∼21 d). Considering that the homozygous EdnrB mutant is lethal and believing that a partial knockout would be pharmacologically relevant, we used heterozygous (EdnrB
) mice for all of our experiments (Fig. 2B) . The body weights of EdnrB −/+ were similar to those of age-matched littermate controls (EdnrB
). Both male and female EdnrB −/+ mice were fertile, and therefore were used as breeding pairs ( Better Performance of EdnrB −/+ Under Extreme Hypoxia. To directly investigate the role of EdnrB in hypoxia adaptation, we examined how EdnrB −/+ responded to 30 min of four levels of O 2 concentration compared with EdnrB +/+ controls. Because the phenotype could be more prominent under extreme conditions, we first investigated whether severe hypoxia (5% O 2 ) induces hypotension, defined as mean arterial pressure (MAP) <40 mmHg. Notably, all of the EdnrB −/+ had MAP >60 mmHg (Fig. 3A and Table S3 ), but (Table S1 ). This site also overlaps a DNaseI-hypersensitive region, observed mainly in blood and lymphatic endothelial cells.
none of the controls could maintain MAP >40 mmHg for the whole 30-min period. This suggests that EdnrB −/+ mice are potentially more resistant to a severe hypoxic challenge. When we investigated further the differences in cardiovascular performance between EdnrB −/+ and EdnrB
, EdnrB −/+ mice clearly had a great advantage over EdnrB
, especially under extreme hypoxia (5% O 2 ). Cardiac output (CO) was remarkably different between the two groups (Fig. 3B) . Whereas there was no difference in the CO between EdnrB +/+ and EdnrB −/+ mice at baseline and in mild hypoxia, namely at 21% and 15%, the difference was significant (P < 0.05) at 10% and 5% O 2 , with CO being stable in the heterozygote but decreased to about half of baseline in the wild type in severe hypoxia. To further our understanding of the differences in cardiovascular function between the two groups of mice, we measured individual pressure-volume parameters. The maximum rate of pressure change (dP/dt max ) per ventricular enddiastolic volume (V ed ), which is a measure of contractility, was higher in the EdnrB −/+ at baseline as well as at all of the subsequent hypoxia exposures (Fig. 3C) .
Comparison of lactate levels also reveals an interesting difference: Whereas the levels were similar between the two groups at room air and 15% O 2 , the difference was prominent as we gradually decreased the O 2 level. At 10% the blood lactate increased significantly in the EdnrB +/+ compared with the EdnrB −/+ , and at 5% O 2 the levels in EdnrB +/+ were more than double that of EdnrB −/+ (Fig. 3D ). There was no significant difference in the arterial O 2 partial pressure (PaO 2 ) between EdnrB −/+ and EdnrB +/+ mice. PaCO 2 in EdnrB −/+ was significantly lower (P < 0.05) in room air but not when O 2 was lowered in inspired air. Interestingly, pH was almost identical between the two groups, except in severe hypoxia, when the blood became more acidic (a significant difference of 0.11 pH units) in the controls than in EdnrB −/+ . Interesting observations were also noted at organ/tissue levels. When the tissues were harvested after the final 5% O 2 exposure and stained using pimonidazole dye, a hypoxia indicator (23), the relative hypoxic area (%) in brain, heart, and kidney was significantly lower in the EdnrB −/+ compared with controls ( Fig. 3E  and Fig. S2) . The difference was more significant in heart tissue. In contrast, no difference was detected in the intestine and liver. Fig. 4C , mauve circles and Inset) in EdnrB −/+ . In addition to this, 39% of differentially expressed genes (1,659; Fig. 4C , blue and red circles and Inset) were in common in both groups. On closer examination, it was interesting to note that there were 16 genes (Fig. 4C, red circles) that were counterregulated by hypoxia (q < 0.05); that is, under hypoxia, these genes were upregulated in EdnrB +/+ and down-regulated in EdnrB −/+ or vice versa. At fragments per kilobase of exon per million reads mapped (FPKMs) ≥2 there were 10 genes oppositely expressed (Fig. 4D and Fig. S3 ) and, as highlighted in Table 1 
Differential Gene Expression in EdnrB
. Of the counterregulated genes, we decided to focus on three genes, namely natriuretic peptide type A (Nppa), sarcolipin (Sln), and myosin light polypeptide 4 (Myl4), because their average FPKM values were >100 and because we validated these three genes (Fig. 4E) by RT-PCR. Interestingly, these three genes were also differentially expressed at baseline (normoxia) when EdnrB +/+ and EdnrB −/+ were compared. We ). The difference appears more significant in heart tissue. No difference in the % hypoxic area is detected in the intestine and liver. † P < 0.05; error bar represents ± SD. then used GeneMANIA (24) to identify the final composite networks of these three oppositely expressed genes (Fig. 4F) . The functions related to these networks were primarily related to Ca 2+ homeostasis, regulation of ATPase activity, regulation of the force of heart contraction, and blood circulation, consistent with the better cardiovascular performance of EdnrB −/+ under extreme hypoxia. Simultaneously, we also studied the genes closely interacting with EdnrB. Most importantly, the ligand Edn-1 (or ET-1) under normoxia had similar Edn-1 expression in both groups, and this was also the case at the protein level when measured in circulating plasma (2.64 ± 0.39 and 2.88 ± 0.26 pg/mL in EdnrB , respectively, at 11% O 2 ).
Discussion
In Udpa et al. (4), we reported that EDNRB is one of the top candidate genes underlying hypoxia adaptation in Ethiopian highlanders. Indeed, there was a strong signature of positive selection in the DNA region containing the EDNRB gene, in the form of a large block of (differential) SNPs that were fixed in the highlanders but at a significantly lower frequency in nearby lowlander populations. Although none of the SNPs were in the coding regions, many of these SNPs were overlying a cluster of transcription-factor binding sites identified in ENCODE ( Fig. 1 A and B) , where the underlying transcription factors were reported to have roles in endothelin-mediated cardiac function (16, 18, 19) . Promoter luciferase assay of the EDNRB gene indicated an 89-fold increased activity with an intact 1,258-bp promoter sequence and a further boost of 2.7-and 3.1-fold with overexpression of c-Jun or C/EBPb, respectively (21) . Additionally, the promoter region was also found to be rich in CpG dinucleotide repeats, and methylation of this CpG-riched region reportedly regulates EDNRB gene expression (25) . It is therefore important to note that the "differential" SNPs in the DNA region containing the EDNRB gene may have a regulatory role, still unexplored. Although these observations do not unequivocally characterize EDNRB to be of a higher or lower level in the Ethiopian highlanders, they do imply the presence of a regulatory connection between transcription and the level of EDNRB. We believe that understanding HA adaptation (or maladaptation) is important not only for better treatment or prevention of disease at HA but also for better understanding and therapy of sealevel diseases that involve hypoxia as a major etiologic factor in pathogenesis. Here we show, to our knowledge for the first time, that indeed, EDNRB, a candidate gene we identified in HA adaptation, proves to be critical in protecting cardiac function in moderate to severe hypoxia at sea level. The receptor itself is one of two known endothelin receptors, the other being EDNRA. The protein encoded by EDNRB is a G protein-coupled receptor that activates a phosphatidylinositol/calcium second-messenger system (26) . Whereas EDNRA is present on the cell membrane, EDNRB is also present on the nuclear membrane and is associated with regulation of nuclear Ca 2+ signaling (27) . The two receptors usually have opposing actions, EDNRA in vasoconstriction and EDNRB in vasodilatation. However, due to the tissue-specific vasoconstrictor role of EDNRB, the reports on this receptor are often contradictory (28) . Interestingly, in humans, the EDNRB gene is well-known for its role in neural crest cell migration, proliferation, and differentiation, where a mutation in this gene may lead to phenotypes such as the aganglionosis of the entire gut (Hirschsprung's disease, megacolon) (29) and hearing loss (30, 31) . Studies have also shown downregulation of EDNRB in human melanoma (32, 33) , colorectal cancer (25) , bladder cancer (34) , and renal cell carcinoma (35) .
In the heart, specifically in the ventricles, the ratio of EDNRA to EDNRB density is reportedly 4:1 (36) . However, studies on cardiac-specific knockout of EdnrA indicated that type A receptors were unnecessary in baseline cardiac function and also under stressful conditions (37) . This clearly indicates a more significant role of EDNRB in cardiac tissues and would correlate with bosentan-related type A and type B receptor antagonism, improvement in cardiac performance, and microcirculatory blood flow during septic shock (38, 39) . When a type A receptorspecific antagonist was administered during porcine endotoxin shock, it only antagonized pulmonary hypertension and had no . (E) Log 2 fold-change comparison between RNA-seq and RT-PCR for the three genes (Nppa, Sln, and Myl4) with FPKM >100. (F) Network analysis of Nppa, Sln, and Myl4 along with EdnrB (striped brown circles) reveals the top-scoring networks (colored circles) all related to cardiovascular function ranging from heart contraction, blood circulation, and the cGMP metabolic process to Ca 2+ homeostasis. effect on the deteriorated cardiac performance (14) . This would suggest that the type B-specific antagonist property of bosentan was involved in improving cardiac performance. Evidence has been accumulating to implicate EdnrB in cardiac function, where an increased expression of vascular EDNRB in patients with ischemic heart disease (40, 41) is seemingly beneficial when the expression is reduced. In addition, pharmacological agents blocking the intracellular loop 2 of EdnrB also appear beneficial under hypoxic conditions (42) . We demonstrate in this work that EdnrB −/+ mice withstand various levels of hypoxia, even severe hypoxia, by maintaining cardiac performance close to that at baseline. For example, cardiac function in EdnrB −/+ was better-maintained under moderate and severe hypoxia than in control mice, and our data (Fig. 3) are consistent with an increase in contractile force and contraction and relaxation velocities of the left ventricle (43, 44) . Previous hypoxia studies on an EdnrB-deficient (EdnrB sl/sl ) rat model missed this very important phenotype in the heterozygote (EdnrB +/sl ), as they treated rats at 10% O 2 (45, 46) . Indeed, we know from our results that the significant drop of CO in EdnrB +/+ and sustenance of CO among EdnrB −/+ are more profoundly visible at 5% O 2 (Fig. 3B) . It is worth noting that a complete knockout of EdnrB even in specific cells may be deleterious (47) .
Because EdnrB −/+ mice maintain better cardiac performance under various levels of hypoxia, we argue that a down-regulated level of EDNRB receptor in EdnrB −/+ mice is sufficient for normal functioning, as seen in normoxia (P > 0.05). However, in severe hypoxic conditions, a lower EDNRB modulates certain genes/pathways that would increase cardiac contractility, thus achieving higher CO.
Cardiovascular or metabolic parameters (such as the dP·dt max
and lactate level) started to change at a level of O 2 of ∼10-13%, altitudes that our Ethiopian subjects came from. Previous studies have also demonstrated indeed that HA dwellers have a lower chance of dying from ischemic heart disease (48), which may relate to better cardiac function. In our heterozygous mice, the remarkable cardiac contractility was associated with a higher peripheral blood flow and better O 2 delivery to vital organs (Fig. 3) especially under extreme hypoxic stress, as evidenced by a lower blood lactate level (Fig. 3D ) and reduced hypoxic areas in vital organs (Fig. 3E) .
To gain insight into the regulatory mechanisms that might explain the phenotypic advantage that we observed in EdnrB −/+ , we used a series of measures to shortlist specific candidate genes from the whole-genome transcriptome profile. In particular, we used a Bayesian approach, conditioning the criteria for mining specific genes and pathways. For example, because the phenotype is so different between the wild-type and the heterozygote, we were interested in focusing on genes that were statistically significant at baseline (normoxia) and during hypoxia and also on genes that changed in different directions when wild type and heterozygote were compared. As depicted, three counterregulated genes (Nppa, Sln, and Myl4; q < 0.05) stand apart from the rest by having an average FPKM >100 and by RT-PCR validation. These three genes are differentially expressed in normoxia as well as hypoxia, and we believe that they are involved in the phenotypic difference between the EdnrB +/+ and EdnrB
. Of interest, we note that these genes are expressed in the fetal heart (49, 50), possibly adding some evidence to a role in hypoxia, because gene expression of fetal transcripts can often show up during stress (51) . As anticipated, the top-scoring networks for these genes were all related to cardiovascular function ranging from heart contraction, blood circulation, and the cGMP metabolic process to Ca 2+ homeostasis (Fig. 4F) . It is known that the endothelin system not only stimulates the secretion of Nppa (52) but that they also counteract each other in some cardiovascular, renal, and endocrine functions (53) . Furthermore, previous studies have also demonstrated that Nppa secretion occurs via an EDNRB-mediated pathway involving the MAPK signaling pathway (54) , and MAPK along with PI3K pathways regulate the hypoxia-induced Nppa secretion by controlling HIF-1α (55) . Studies using Nppa null (Nppa −/− ) mice also provide evidence that Nppa plays an important role in pulmonary vascular adaptation to chronic hypoxia (56) . Similarly, Sln regulates Ca 2+ uptake through interaction with sarcoplasmic reticulum Ca 2+ ATPase (SERCA). Like Nppa, Sln is also normally expressed at high levels in atria, and its expression is at very low/ undetectable levels in ventricles (57), except in some conditions when it is increased by several-fold, such as in patients with preserved left ventricular ejection fraction and chronic isolated mitral regurgitation, where there is >10-fold increased expression of both Nppa and Sln (58). Therefore, altered Nppa and Sln expression may contribute to impaired Ca 2+ handling, and our study indicates that their cross-talk with EdnrB could lead to better cardiac performance under extreme hypoxia. Myl4, the third prioritized gene, is also atriaspecific in the adult. Interestingly, it is reexpressed in the ventricles of the diseased heart, suggesting a role in repair mechanisms (59) . The up-regulation of Myl4 in EdnrB −/+ indicated cross-talk between the two genes (EdnrB and Myl4). This notion is supported by a recent study showing that Myl4 in the left ventricle was differentially regulated under the protective influence of endothelin receptor inhibitors, including BQ788 (EdnrB-specific), which protects against doxorubicin-induced cardiomyopathy (60) .
One question that can be raised is whether our results are relevant to understanding mechanisms of HA hypoxia adaptation. Although this question is difficult to answer, our observation that decreasing EdnrB expression (a gene we identified in HA dwellers) is beneficial for cardiovascular performance is in itself very illuminating. This is of particular interest especially because the results that we obtained are in acute hypoxia. Indeed, these data become relevant to the treatment of many more patients suffering from diseases that have acute hypoxia as part of their etiology at sea level.
In summary, we have demonstrated, for the first time to our knowledge, how an experiment in nature at high altitude in human adaptation could provide insight into disease mechanisms in acute forms involving hypoxia and ischemia at sea level. This is supported by our observation in knockout mice where EdnrB −/+ mice were resistance to various levels of hypoxia, maintaining higher CO and peripheral perfusion and better DO 2 to vital organs, even in severe hypoxia. The idea that reducing the expression of functional EDNRB helps cells/tissues endure extreme hypoxia is appealing, and may forage novel therapy for cardiac failure in the near future. A transcriptome profile from ventricular tissue revealed three atria-specific genes, Nppa, Sln, and Myl4, which likely play a role in the improved cardiac performance during hypoxia in the heterozygote mouse.
Materials and Methods
Genomic Reanalysis of the Whole-Genome Seq Data. We systematically searched and compared published/publicly available data [Genotype-Tissue Expression (GTEx), Genetic European Variation in Health and Disease (GeuVadis), and ENCODE project] with our seq data (4) that may further support the regulation or disregulation of EDNRB [ideally via our observed SNPs as a significant expression quantitative trait loci (eQTL) for EDNRB] in human studies. See SI Materials and Methods for full methods.
Generation of the EdnrB Knockout and Its Validation. All animal care and handling were performed according to the protocols approved by the Animal Care Committee of the University of California, San Diego. We generated global knockout mice for EdnrB, where exon 3 of the EdnrB gene was completely removed, resulting in an out-of-frame transcript of exon 2-4 splicing. A schematic of the breeding strategy and its validation using RT-PCR are provided in SI Materials and Methods and Fig. S1A .
Mouse Preparation for Hypoxia Treatment. Animal handling and care followed the NIH Guide for the Care and Use of Laboratory Animals (61) . Detailed steps are provided in SI Materials and Methods. Briefly, the mice were anesthetized to implant arterial catheters (PE-50) into the carotid artery and used for hypoxia treatment after a 24-h recovery. The inclusion and exclusion criteria are as mentioned in SI Materials and Methods. Further experimental details for the immunohistochemistry, ELISA, and statistical analysis are presented in SI Materials and Methods.
RNA-Seq Data Generation and Analysis. We used 500 ng of RNA with an RNA integrity number of 8 or greater to generate libraries using Illumina's TruSeq Stranded mRNA Sample Prep Kit. Details are in SI Materials and Methods.
